Transcriptome characterization by RNA sequencing identifies a major molecular and clinical subdivision in chronic lymphocytic leukemia

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

Figure 5.
Figure 5.

Clinical behavior of the C1 (green) and C2 (red) subgroups. (A) Distribution of clinico-biological features in the RNA-seq profiled patients. (B) Time to treatment in the RNA-seq profiled patients at Binet stages A and B. (C) Distribution of clinico-biological features in the microarray profiled patients from the independent validation series. (D) Time to treatment in the microarray-profiled patients from the independent validation series at Binet stages A and B.

This Article

  1. Published in Advance November 21, 2013, doi: 10.1101/gr.152132.112 Genome Res. 24: 212-226

Preprint Server



Current Issue

  1. March 2026, 36 (3)
  1. Current Issue
  1. Alert me to new issues of Genome Research